BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1581420)

  • 1. Resistance of Ha-ras oncogene-induced progressor tumor variants to tumor necrosis factor and interferon-gamma.
    Fernandez A; Chen PW; Aggarwal BB; Ananthaswamy HN
    Lymphokine Cytokine Res; 1992 Apr; 11(2):79-85. PubMed ID: 1581420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response to progressor variants derived from transfection of an ultraviolet radiation-induced C3H mouse regressor tumor cell line with activated Harvey-ras oncogene.
    Kaba DS; Pierceall WE; Price JE; Ananthaswamy HN
    Cancer Res; 1990 Jun; 50(11):3159-66. PubMed ID: 2185882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential sensitivity of normal and Ha-ras-transformed C3H mouse embryo fibroblasts to tumor necrosis factor: induction of bcl-2, c-myc, and manganese superoxide dismutase in resistant cells.
    Fernandez A; Marin MC; McDonnell T; Ananthaswamy HN
    Oncogene; 1994 Jul; 9(7):2009-17. PubMed ID: 8208546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major histocompatibility complex class I and unique antigen expression by murine tumors that escaped from CD8+ T-cell-dependent surveillance.
    Ward PL; Koeppen HK; Hurteau T; Rowley DA; Schreiber H
    Cancer Res; 1990 Jul; 50(13):3851-8. PubMed ID: 2112981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between inducible H-2 expression and the immunogenicity of murine skin neoplasms. I. Evidence that the immunogenicity of ultraviolet radiation-chemically induced tumors is associated with their susceptibility to gamma-interferon-mediated enhancement of H-2Kk expression.
    Burnham DK; Mak CK; Webster RJ; Daynes RA
    Transplantation; 1989 Mar; 47(3):533-42. PubMed ID: 2493701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune response to somatic cell hybrids between ultraviolet radiation-induced regressor and spontaneous progressor C3H mouse tumor cells.
    Chen PW; Kaba DS; Ananthaswamy HN
    Cancer Res; 1990 Mar; 50(5):1544-9. PubMed ID: 2137370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Augmentation of vaccination effects of PGE2-producing tumor cells by transfection with cytokine genes].
    Ohiro Y
    Hokkaido Igaku Zasshi; 1997 May; 72(3):273-84. PubMed ID: 9226467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the tumor necrosis factor gene in tumor cells correlates with reduced tumorigenicity and reduced invasiveness in vivo.
    Vanhaesebroeck B; Mareel M; Van Roy F; Grooten J; Fiers W
    Cancer Res; 1991 Apr; 51(8):2229-38. PubMed ID: 2009541
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ras-induced neoplastic transformation and sensitivity to tumor necrosis factor.
    Fernandez A; Chen PW; Ananthaswamy HN
    Anticancer Res; 1994; 14(6B):2649-52. PubMed ID: 7872696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two discrete types of tumor necrosis factor-resistant cells derived from the same cell line.
    Vanhaesebroeck B; Van Bladel S; Lenaerts A; Suffys P; Beyaert R; Lucas R; Van Roy F; Fiers W
    Cancer Res; 1991 May; 51(9):2469-77. PubMed ID: 1849793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of MHC class II antigen expression. Opposing effects of tumor necrosis factor-alpha on IFN-gamma-induced HLA-DR and Ia expression depends on the maturation and differentiation stage of the cell.
    Watanabe Y; Jacob CO
    J Immunol; 1991 Feb; 146(3):899-905. PubMed ID: 1899098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide synthase is induced in tumor promoter-sensitive, but not tumor promoter-resistant, JB6 mouse epidermal cells cocultured with interferon-gamma-stimulated RAW 264.7 cells: the role of tumor necrosis factor-alpha.
    Murakami A; Kawabata K; Koshiba T; Gao G; Nakamura Y; Koshimizu K; Ohigashi H
    Cancer Res; 2000 Nov; 60(22):6326-31. PubMed ID: 11103793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ha-ras oncogene expression abrogates a pH dependent endonuclease activity of apoptosis in normal rat kidney cells.
    Ostad M; Shu WP; Kong L; Liu BC
    Cancer Lett; 1996 Jan; 98(2):175-82. PubMed ID: 8556706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro induction of inhibitory macrophage differentiation by granulocyte-macrophage colony-stimulating factor, stem cell factor and interferon-gamma from lineage phenotypes-negative c-kit-positive murine hematopoietic progenitor cells.
    Ferret-Bernard S; Saï P; Bach JM
    Immunol Lett; 2004 Feb; 91(2-3):221-7. PubMed ID: 15019293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokines alter target cell susceptibility to lysis: I. Evaluation of non-major histocompatibility complex-restricted effectors reveals differential effects on natural and lymphokine-activated killing.
    Wiebke EA; Custer MC; Rosenberg SA; Lotze MT
    J Biol Response Mod; 1990 Apr; 9(2):113-26. PubMed ID: 2111373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
    Hoon DS; Banez M; Okun E; Morton DL; Irie RF
    Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of transcription factor interferon regulatory factor-1 by interferon-gamma (IFN gamma) and tumor necrosis factor-alpha (TNF alpha) in FRTL-5 cells.
    Mori K; Stone S; Khaodhiar L; Braverman LE; DeVito WJ
    J Cell Biochem; 1999 Aug; 74(2):211-9. PubMed ID: 10404391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
    Patek PQ; Lin Y
    J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased in vitro and in vivo tumoricidal activity of a macrophage cell line genetically engineered to express IFN-gamma, IL-4, IL-6, or TNF-alpha.
    Nishihara K; Barth RF; Wilkie N; Lang JC; Oda Y; Kikuchi H; Everson MP; Lotze MT
    Cancer Gene Ther; 1995 Jun; 2(2):113-24. PubMed ID: 7621259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma and tumor necrosis factor-alpha induce synergistic cytolytic effects in ovarian cancer cell lines-roles of the TR60 and TR80 tumor necrosis factor receptors.
    Kost ER; Mutch DG; Herzog TJ
    Gynecol Oncol; 1999 Mar; 72(3):392-401. PubMed ID: 10053112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.